NCT04564521View on ClinicalTrials.gov

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2024

Conditions
Retinoblastoma
Interventions
DRUG

Nitroglycerin

Intravenous nitroglycerin (0.5mcg/kg/min) is infused after the induction of general anesthesia and during intra-arterial chemotherapy to reduce the cardio-respiratory side effects.

DRUG

Normal saline

Intravenous normal saline is infused after the induction of general anesthesia and during intra-arterial chemotherapy as an active comparator.

Trial Locations (1)

Unknown

RECRUITING

Jin-Tae Kim, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER